I disagree. Brazil is our ONLY shot at proving LL works for critical Covid. If one accepts the science and MOA, the new protocol should almost undoubtedly succeed. The enrollment mistakes will be avoided too, per Dr. Recknor.

Therefore, Brazil *not* starting means a whole indication and the fastest approval will not happen. I feel right now the market/PPS believes it’s not going to happen. Another fizzled out adventure has been priced in.

If the Brazil trial *does* start then it virtually (99%) guarantees successful results and EUA(s). That is why IMO the price will move. Maybe not enormously but it will budge. Smart shorts would be wise to go long at that juncture.

FWIW I too have heard from a few sources that it’s “imminent.”